Abstract:OBJECTIVE:To study the clinical characteristics of patients with post-transplantation lymphoproliferative disease (PTLD) after allogeneic peripheral blood hematopoietic stem cell transplantation, and to improve the understanding and diagnosis of PTLD.METHODS:The clinical data of 244 patients underwent allogeneic hematopoietic stem cell transplantation in the General Hospital of PLA from May 2014 to April 2017 were analyzed retrospectively. The follow-up time was up to November 30, 2017. The incidence, risk factors, treatment and survival of patients with PTLD were statistically analyzed.RESULTS:Among the 244 cases the PTLD occurred in 22 cases, the incidence rate was 9.02%, 5 of them were diagnosed by pathology, and 17 were diagnosed clinically. All of them had EB virus infection. They were all ATG user, either underwent related haploidentical hematopoietic stem cell transplantation or unrelated hematopoietic stem cell transplantation, 20 cases were treated with rituximab or rituximab combined with γ-globulin, glucocorticoid, ERV+CTL, chemotherapy and 17 showed the effective response, with a total effective rate of 85%. The median follow-up time was 122 days, the median survival time was 5 months (1-22 months) and the total survival rate was 50%.CONCLUSION:The incidence of PTLD after allogeneic peripheral blood hematopoietic stem cell transplantation closely relates with EB virus infection. The application of ATG in the preconditioning scheme is a high risk factor for the onset of PTLD. In the case of no pathological diagnosis, clinical and laboratory examinations should be actively combined so as to define clinical diagnosis. The riturimab should be used more and more for patients with PTLD.

Effects of PTTG gene expression on the reproductive ability of non-hodgkin lymphoma cells

The effect of PTTG gene silenced by RNAi on inhibition of human glioblastoma U251 cells

Effect of Hpttg1 Sirna on Proliferation and Apoptosis of Ovarian Cancer Cells

Effects of Mcl-1 gene expression on the reproductive ability of non-Hodgkin lymphoma cells

[Clinical Study of P-gp, and Bcl-2 Protein Expression in Non-Hodgkin's Lymphomas Patients].

Silence Effects of Double Interfering Vector Targeting PTTG and Survivin Genes on U251 Cells

Introduction of Plasmid-Mediated Exogenous Microrna to Silence PTTG1 Gene Expression and Inhibit Proliferation and Invasiveness of Glioma Cells HUANG Qing-feng, LU Yi-eheng, BAI

[Analysis of Expression Profiles of Some Tumor Growth-Related Genes after Silencing of Pleiotrophin in Human Small Cell Lung Cancer H446 Cells].

Effect of PTTG1 in the invasion of glioma cells

PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186.

Expression and its significance of pituitary tumor transforming gene PTTG in NHL

The expression of pituitary tumor transforming gene (PTTG) in breast cancer and its clinical significance

Elementary Studies on Effect of PTTG Gene Expression in Human Primary Hepatocellular Carcinogenesis and Its Mechanism

Influence of PTEN on Proliferation of Colon Cancercell HCT-8 by Sirna

Pituitary Tumor Transforming Gene-1 in Non-Small Cell Lung Cancer: Clinicopathological and Immunohistochemical Analysis

Construction of PTTG Sirna Expressing Vector and Evaluation of Its Gene Silencing Efficiency

The expression and significance of PTTG and bFGF in non-Hodgkin's lymphoma

The effect of long non-coding RNA PVT1 silencing on K562 cell proliferation

Methylation Status of PTPL1 Gene in Non-Hodgkin's Lymphoma Cells

Effects of NK4 gene on the proliferatoi n of non-Hodgkin lymphoma cells

[Clinical Characteristics, Treatment and Prognosis of PTLD after Allogeneic Hematopoietic Stem Cell Transplantation].